Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NARA.CNthis companyPangenomic Health Inc.	CA$0.30	-2.42×	-3.87×	0×	-2.53×	-135.1%	0.0%	0.0%	0.0%	156.8%	173.2%	-22.2%	-0.1×	-0.05×	-835.72×	0.07×	0.0%	2	-346.8	—	—
AIML.CNAI/ML Innovations Inc.	CA$0.04	-1.5×	-12.15×	114.91×	-1.6×	-114.1%	-3310.4%	-7811.3%	-7652.0%	809.4%	-4637.1%	-56.7%	-1.23×	-0.11×	-138.1×	0.73×	0.0%	1	-42.17	2	C
BLAB.CNBritannia Life Sciences Inc.	CA$0.07	1.12×	0.7×	30.75×	-9.69×	-103.5%	8.2%	-306.8%	2753.4%	63.0%	-6.6%	-7.9%	0.01×	0.79×	-57.36×	6.57×	0.0%	6	3.03	4	A+
DOSE.CNRapid Dose Therapeutics Corp.	CA$0.10	-5.88×	-2.78×	7.19×	-15.23×	-398.4%	-34.5%	-78.3%	-122.2%	47.2%	117.1%	-1.4%	-0.74×	-3.2×	-1.78×	0.04×	0.0%	3	-27.84	2	C
HEM.VHemostemix Inc.	CA$0.05	-3.13×	-2.96×	0×	-4.14×	-154.2%	0.0%	0.0%	0.0%	94.8%	637.9%	-30.8%	-0.72×	-0.69×	-10.05×	0.49×	0.0%	1	-454.38	2	C
PREV.CNPreveCeutical Medical Inc.	CA$0.02	-8.93×	-2.28×	0×	-13.95×	-137.9%	0.0%	0.0%	0.0%	25.4%	339.0%	-12.1%	-0.75×	-3.45×	-10.44×	0.15×	0.0%	2	-35.09	1	C-
Peer median	—	-3.13×	-2.78×	7.19×	-9.69×	-137.9%	0.0%	-78.3%	0.0%	63.0%	117.1%	-12.1%	-0.74×	-0.69×	-10.44×	0.49×	0.0%	2	-35.09	2	—